🇯🇵 日本語 🇺🇸 English
3,817 companies 12,975 AI summaries 9,784 risk analyses 5,404 growth scores Register free — watchlist & alerts →
EDINET 4750 Negative Risk Analyzed 📈 Growth 3/10

DAISAN CO.,LTD.

Semi-Annual Report - 24th Term(2026/04/01 - 2027/03/31) ／ 2026-11-13 16:29

Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).

New Product
AI Summary 2026-11-13 16:41

GIMIC Co., Ltd. (medical-specialized platform business) reported H1 FY2026 results (Apr-Sep 2026): Revenue ¥1,936M (+3.2% YoY) showed steady growth, while operating profit ¥118M (-53.3%) and net income ¥109M (-39.4%) declined sharply due to increased SG&A expenses. Equity ratio improved to 78.7%.

KEY POINTS
  • Revenue growth steady at +3.2%, but operating/net profit fell sharply (-53.3%, -39.4%)
  • SG&A expenses surged (¥1,284M → ¥1,446M, +12.6%)
  • Equity ratio strengthened to 78.7% (from 73.3%), solidifying balance sheet
  • Newly deposited ¥1,000M in time deposits, shifting cash management strategy
📊 Revenue
Revenue +3.2% (¥1,877M → ¥1,936M)
💰 Operating profit
Operating profit -53.3% (¥254M → ¥118M); Net income -39.4% (¥180M → ¥109M)
🔮 Outlook
Not stated
📈 Growth outlook 📈 Growth 3/10
Modest growth momentum (+3.2% revenue) with low pace. Core "Doctor's File" business continues, but profit decline raises efficiency concerns. Brand awareness initiatives (movie 5.66M views) ongoing but in measurement phase.
Growth drivers
  • Expansion of regular publication of 'Reliable Doctor' medical magazine with 8 new editions released
  • Brand movie release boosting Doctor's File awareness (5.66M views)
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
CategoryDescriptionScoreNew
Deteriorating Performance Risk Operating profit declined 53.3% with significant margin compression. If SG&A expense increase (+12.6%) persists, further profit pressure expected. 7/10 NEW
Market Risk Healthcare matching platform market faces intensifying competition. Long-term risk from declining medical facilities and patient numbers due to demographic aging. 6/10 NEW
Customer Concentration Risk Revenue heavily dependent on 'Doctor's File' (72.3% of sales). Over-reliance on single platform poses business continuity risk. 6/10 NEW
Competitive Intensification Risk Competitive pressure rising from major IT firms and new entrants in healthcare information/matching. Risk of rising user acquisition costs. 6/10
Cybersecurity Risk As medical platform holding patient and physician data, vulnerable to data breach/unauthorized access risking reputation damage. 6/10
Regulatory Risk Healthcare advertising regulations tightening. Potential business impact from changes in medical information credibility standards. 5/10 NEW
Technology Risk Digital platform business highly vulnerable to system failures/cyberattacks causing business stoppage. Recovery infrastructure development progress unclear. 5/10
7/10 NEW Deteriorating Performance Risk
Operating profit declined 53.3% with significant margin compression. If SG&A expense increase (+12.6%) persists, further profit pressure expected.
6/10 NEW Market Risk
Healthcare matching platform market faces intensifying competition. Long-term risk from declining medical facilities and patient numbers due to demographic aging.
6/10 NEW Customer Concentration Risk
Revenue heavily dependent on 'Doctor's File' (72.3% of sales). Over-reliance on single platform poses business continuity risk.
6/10 Competitive Intensification Risk
Competitive pressure rising from major IT firms and new entrants in healthcare information/matching. Risk of rising user acquisition costs.
6/10 Cybersecurity Risk
As medical platform holding patient and physician data, vulnerable to data breach/unauthorized access risking reputation damage.
5/10 NEW Regulatory Risk
Healthcare advertising regulations tightening. Potential business impact from changes in medical information credibility standards.
5/10 Technology Risk
Digital platform business highly vulnerable to system failures/cyberattacks causing business stoppage. Recovery infrastructure development progress unclear.
X LinkedIn Threads Bluesky Facebook
Track Japanese disclosures with JSIGNAL

AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.

Start free — 30-day trial Login